January 28, 2021

The Niche

Trusted stem cell blog & resources

Riken

2 min read

In a surprise, Dr. Masayo Takahashi has announced that she has left RIKEN. Takahashi indicates she will be new President of a company called Vision Care, Inc. as part of the Kobe Eye Center. I’ve pasted a picture of Takahashi’s Tweet with translation more toward the bottom of the post. A big thanks to Piero Carninci, a biologist at RIKEN, for the heads up on this news. I’m sure they are very sad to see her go, but wish her the best! Here is …Read More

3 min read

The Japanese research institute RIKEN has come full circle in a way on the STAP cell scandal. Note that the STAP papers included not only authors from RIKEN, but also from Brigham and Women’s Hospital/Harvard Medical School. With its final report released today (also a powerpoint of images were released including the one showing a figure posted here of reportedly made up data published in a STAP paper), RIKEN seems to now have handled this complicated mess in a relatively rigorous, scientific manner that …Read More

2 min read

Dr. Yoshiki Sasai (笹井芳樹) former Deputy Director of the RIKEN CDB and a senior author on the STAP papers, has reportedly died from suicide. Update: The Japan Times writes on this situation that Sasai was found hanging at RIKEN and there may have been a suicide note. Dr. Sasai was a top scholar in the stem cell field. He published dozens of high-impact publications and was widely respected. You can see some thoughts on the loss of Yoshiki Sasai from Scientific American here by Janet D. …Read More

3 min read

What’s going on with the STAP cell situation now that it is into its third month? It’s getting worse instead of better or clearer, at least in part due to RIKEN’s incomplete investigation. What’s going on with STAP? New RIKEN Press Conference RIKEN reportedly held an odd sort of limited press conference today that TJO has tweeted was not encouraging at all (see above the first in TJO’s series of Tweets). I highly recommend following TJO on Twitter. Apparently RIKEN is still greatly limiting the scope …Read More

2 min read

If you are wondering, “How will iPS cells get to help patients?” part of the answer is perhaps the big player and Japanese Institution, Riken and its arm Retina Institute of Japan. The stem cell field is still abuzz about induced pluripotent stem (iPS) cells 7 years after their discovery. This amazing embryonic stem cell-like cells can be made with no embryo and have the potential for truly patient specific therapies as well as dish-in-a-dish modeling and drug discovery.   iPS cells are being commercialized and …Read More